A possible mechanism of induction and translocation into blood stream of rat alkaline phosphatase activity by bile duct ligation.
We investigated the effects of bile duct ligation on alkaline phosphatase (ALP) activities in liver, calvarium, duodenum, and ileum in rats and its possible mechanism of action. ALP isozyme activities in the ligated rats were significantly elevated in the liver and duodenum, while those in the ileum and calvarium were markedly decreased. The ALP isozyme activity elevated by the ligation was obviously suppressed by prior administration of indomethacin, an inhibitor of prostaglandin synthesis. Moreover, phorbol ester also elevated the ALP activity as well as the phosphatase level in the ligated rat. However, other drugs, such as an inhibitor of protein kinase C and calmodulin, showed different effects: calmodulin stimulated an 11.0-, 1.3-, or 1.5-fold increase in ALP activity in the ileum, duodenum, or calvarium, respectively; whereas the hepatic enzyme activity was not affected. The induction by calmodulin was markedly different from that by the ligation. Moreover, imipramine, an inhibitor of protein kinase C, had little effect. These results suggest that prostaglandin is a possible ALP inducer in ligated rats, probably working by elevating the cAMP level. On the other hand, the ligation induced simultaneously de novo synthesis of the membranous and soluble ALP isozymes; and the release rate of the soluble enzyme was greater than that of the membranous isozymes, indicating that the soluble enzyme might be a main source of the induced serum ALP. Lectin affinity chromatography indicated that the soluble enzyme or induced serum enzyme may contain more fucose than that of the membranous one, suggesting that the sugar moiety in the ALP molecule may relate to the clearance of ALP from or its release into the circulation.
D000469:Alkaline Phosphatase / Q000097:blood / Q000378:metabolism*; D000818:Animals; D001652:Bile Ducts / Q000502:physiology* / Q000601:surgery; D001842:Bone and Bones / Q000201:enzymology; D002147:Calmodulin / Q000378:metabolism; D002746:Chlorpromazine / Q000494:pharmacology; D002779:Cholestasis / Q000201:enzymology*; D000242:Cyclic AMP / Q000378:metabolism; D004790:Enzyme Induction; D004815:Epidermal Growth Factor / Q000378:metabolism; D005643:Fucose / Q000378:metabolism; D007213:Indomethacin / Q000494:pharmacology; D007422:Intestines / Q000201:enzymology; D007527:Isoenzymes / Q000378:metabolism; D008026:Ligation; D008099:Liver / Q000201:enzymology; D011453:Prostaglandins / Q000378:metabolism; D011493:Protein Kinase C / Q000378:metabolism; D051381:Rats; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology
D002147:Calmodulin; D007527:Isoenzymes; D011453:Prostaglandins; D005643:Fucose; D004815:Epidermal Growth Factor; D000242:Cyclic AMP; D011493:Protein Kinase C; D000469:Alkaline Phosphatase; D013755:Tetradecanoylphorbol Acetate; D002746:Chlorpromazine; D007213:Indomethacin